Cardiac Toxicity Active Not Recruiting Phase 2 Trials for Doxorubicin (DB00997)

IndicationStatusPhase
DBCOND0028520 (Cardiac Toxicity)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00436566Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By SurgeryTreatment